Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma In 2011: A Year Of Transition

Jan 24 2012

Related Content

Biogen Tests Biosimilars Waters In Joint Venture With Samsung

Dec 12 2011

Yervoy Cuts To The Head Of The Line: Ipilimumab Has Unrestricted Label

Mar 28 2011

<i>Zelboraf</i> Approval Hastened By FDA Officials Impressed With Early Efficacy

Aug 22 2011

Intermune’s Esbriet Flops In Front Of IQWiG

Dec 19 2011

With Its Economy Struggling, Spain Launches Second Cost-Cutting Exercise In Two Years

Aug 08 2011

Merck/Roche Co-Promote Pact Attempts To Shut Vertex Out Of HCV Protease Inhibitor Space

May 17 2011

Germany's IQWiG Gives Partial Nod To AZ's Brilinta In First Added-Benefit Assessment

Oct 05 2011

Forma To Play To Its Strengths WIth Genentech Deal

Jul 01 2011

Some VC Funds Have Miles To Go While Others Have Burned What's In The Tank

Jul 01 2011

Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties

Sep 01 2011

Eli Lilly's Open Source Approach To Early Stage Research

Sep 01 2011

Biosimilars: A New Kind Of Innovation

Nov 30 2011

Next-Generation Combination Therapy In Oncology

Nov 30 2011

The Abbott Split Up: Who Wins?

Nov 30 2011

PanGenetics' NGF Antibody Sale Illustrates Index's Asset-Focused Strategy

Dec 01 2009

Investing A La Carte: Making Separate Bets on Discovery and Development to Boost Near-Term Returns

Mar 01 2011

Atlas, CMEA Test New Biotech Model

Apr 01 2011

Pharma/Payor Deals An Important Step In The Shift To Value-Based R&D

Dec 27 2011

Rx Class Action Suits May Come To France In Response To Mediator Scandal

Nov 02 2011

Back To School: Big Pharmas Test New Models For Tapping Academia

Feb 01 2011

IND Over POC: The New Sweet Spot For Biopharma Dealmaking

Oct 01 2011

UK Value-Based Pricing Proposals Aim To Increase Access, Broaden Assessment of Drug Benefits

Dec 17 2010

Lilly's Evolving Corporate Venture Model

Oct 01 2010

Shire And Atlas Venture To Work Together To Incubate Rare Disease Research Projects

Dec 19 2011

Amgen, Watson Aim To Launch First Joint Oncology Biosimilar In U.S. In 2017

Dec 20 2011

AstraZeneca Rebuilds Its R&D, With Payers In Mind

Jul 04 2011

Related Companies

Forma Therapeutics Inc.

Roche Holding AG

Genentech, Inc.

Boehringer Ingelheim GmbH

Johnson & Johnson

Johnson & Johnson

Adimab, LLC

Ablexis LLC

Nimbus Therapeutics, Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Sanofi

Warp Drive Bio, Inc.

Eli Lilly and Company

Arteaus Therapeutics, LLC

Eli Lilly and Company

PanGenetics B.V.

Abbott

Pfizer Inc.

University of California San Francisco

GSK plc

Bayer AG

Biogen, Inc.

Merck & Co., Inc.

Additional Topics

Strategy Business Strategies Clinical Trials Deals Regulation Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window